Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase BTK (Bruton's tyrosine kinase) is a non-receptor protein tyrosine kinase that plays a central role in B-cell development, differentiation, and signaling. Mutations in the *BTK* gene cause X-linked agammaglobulinemia (XLA). Pharmacological inhibition of BTK has emerged as an effective strategy for treating various B-cell malignancies.
Pharmacological inhibition of BTK disrupts oncogenic BCR-mediated survival signals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase BTK (BTK).